PBI13 Budget Impact Analysis to Assess The Impact of Adalimumab-atto (Biosimilar) Compared to Adalimumab in Autoimmune Diseases in United Arab Emirates
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.091
https://www.valueinhealthjournal.com/article/S1098-3015(20)32347-0/fulltext
Title :
PBI13 Budget Impact Analysis to Assess The Impact of Adalimumab-atto (Biosimilar) Compared to Adalimumab in Autoimmune Diseases in United Arab Emirates
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32347-0&doi=10.1016/j.jval.2020.08.091
First page :
Section Title :
Open access? :
No
Section Order :
10063